Pharma-Bio Serv (PBSV) Leases (2016 - 2025)
Pharma-Bio Serv (PBSV) has disclosed Leases for 12 consecutive years, with $29388.0 as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Leases fell 85.2% year-over-year to $29388.0, compared with a TTM value of $29388.0 through Oct 2025, down 85.2%, and an annual FY2025 reading of $29388.0, down 85.2% over the prior year.
- Leases was $29388.0 for Q4 2025 at Pharma-Bio Serv, down from $72747.0 in the prior quarter.
- Across five years, Leases topped out at $790561.0 in Q1 2021 and bottomed at $29388.0 in Q4 2025.
- Average Leases over 5 years is $409359.8, with a median of $412419.0 recorded in 2023.
- The sharpest move saw Leases fell 12.97% in 2021, then plummeted 85.2% in 2025.
- Year by year, Leases stood at $639969.0 in 2021, then dropped by 21.45% to $502685.0 in 2022, then fell by 29.09% to $356450.0 in 2023, then crashed by 44.28% to $198597.0 in 2024, then tumbled by 85.2% to $29388.0 in 2025.
- Business Quant data shows Leases for PBSV at $29388.0 in Q4 2025, $72747.0 in Q3 2025, and $115259.0 in Q2 2025.